• Nektar Therapeutics (NASDAQ:NKTR) Stock Rating Upgraded by Oppenheimer

    Source: Buzz FX / 15 Mar 2025 08:16:17   America/New_York


    Nektar Therapeutics (NASDAQ:NKTR) Stock Rating Upgraded by Oppenheimer Written by MarketBeat March 15, 2025 Share Link copied to clipboard. Remove Ads Nektar Therapeutics ( NASDAQ:NKTR - Get Free Report ) was upgraded by Oppenheimer from a
    Read more...
Share on,